298 related articles for article (PubMed ID: 30515176)
1. Lymphoid Stress Surveillance Response Contributes to Vitiligo Pathogenesis.
Raam L; Kaleviste E; Šunina M; Vaher H; Saare M; Prans E; Pihlap M; Abram K; Karelson M; Peterson P; Rebane A; Kisand K; Kingo K
Front Immunol; 2018; 9():2707. PubMed ID: 30515176
[TBL] [Abstract][Full Text] [Related]
2. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.
Le Poole IC; van den Wijngaard RM; Westerhof W; Das PK
Am J Pathol; 1996 Apr; 148(4):1219-28. PubMed ID: 8644862
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin.
Yu R; Broady R; Huang Y; Wang Y; Yu J; Gao M; Levings M; Wei S; Zhang S; Xu A; Su M; Dutz J; Zhang X; Zhou Y
PLoS One; 2012; 7(12):e51040. PubMed ID: 23251420
[TBL] [Abstract][Full Text] [Related]
4. Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.
Palermo B; Campanelli R; Garbelli S; Mantovani S; Lantelme E; Brazzelli V; Ardigó M; Borroni G; Martinetti M; Badulli C; Necker A; Giachino C
J Invest Dermatol; 2001 Aug; 117(2):326-32. PubMed ID: 11511311
[TBL] [Abstract][Full Text] [Related]
5. Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity.
Lin X; Tian H; Xianmin M
Med Hypotheses; 2011 Mar; 76(3):339-42. PubMed ID: 21075543
[TBL] [Abstract][Full Text] [Related]
6. Presence and the roles of IL-9/Th9 axis in vitiligo.
Kumar S; Marathe S; Dhamija B; Zambare U; Bilala R; Warang S; Nayak C; Purwar R
Pigment Cell Melanoma Res; 2021 Sep; 34(5):966-972. PubMed ID: 33834624
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
van den Boorn JG; Konijnenberg D; Dellemijn TA; van der Veen JP; Bos JD; Melief CJ; Vyth-Dreese FA; Luiten RM
J Invest Dermatol; 2009 Sep; 129(9):2220-32. PubMed ID: 19242513
[TBL] [Abstract][Full Text] [Related]
8. Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo.
Tulic MK; Cavazza E; Cheli Y; Jacquel A; Luci C; Cardot-Leccia N; Hadhiri-Bzioueche H; Abbe P; Gesson M; Sormani L; Regazzetti C; Beranger GE; Lereverend C; Pons C; Khemis A; Ballotti R; Bertolotto C; Rocchi S; Passeron T
Nat Commun; 2019 May; 10(1):2178. PubMed ID: 31097717
[TBL] [Abstract][Full Text] [Related]
9. Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site.
van den Wijngaard R; Wankowicz-Kalinska A; Le Poole C; Tigges B; Westerhof W; Das P
Lab Invest; 2000 Aug; 80(8):1299-309. PubMed ID: 10950121
[TBL] [Abstract][Full Text] [Related]
10. Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.
Wańkowicz-Kalińska A; van den Wijngaard RM; Tigges BJ; Westerhof W; Ogg GS; Cerundolo V; Storkus WJ; Das PK
Lab Invest; 2003 May; 83(5):683-95. PubMed ID: 12746478
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress drives CD8
Li S; Zhu G; Yang Y; Jian Z; Guo S; Dai W; Shi Q; Ge R; Ma J; Liu L; Li K; Luan Q; Wang G; Gao T; Li C
J Allergy Clin Immunol; 2017 Jul; 140(1):177-189.e9. PubMed ID: 27826097
[TBL] [Abstract][Full Text] [Related]
12. Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?
Garbelli S; Mantovani S; Palermo B; Giachino C
Pigment Cell Res; 2005 Aug; 18(4):234-42. PubMed ID: 16029417
[TBL] [Abstract][Full Text] [Related]
13. Vitiligo: where do we stand?
Ortonne JP; Bose SK
Pigment Cell Res; 1993 Mar; 6(2):61-72. PubMed ID: 8321867
[TBL] [Abstract][Full Text] [Related]
14. Initiation and regulation of CD8+T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo.
Steitz J; Wenzel J; Gaffal E; Tüting T
Eur J Cell Biol; 2004 Dec; 83(11-12):797-803. PubMed ID: 15679123
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of melanocyte death in vitiligo.
Chen J; Li S; Li C
Med Res Rev; 2021 Mar; 41(2):1138-1166. PubMed ID: 33200838
[TBL] [Abstract][Full Text] [Related]
16. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi.
van Geel NA; Mollet IG; De Schepper S; Tjin EP; Vermaelen K; Clark RA; Kupper TS; Luiten RM; Lambert J
Pigment Cell Melanoma Res; 2010 Jun; 23(3):375-84. PubMed ID: 20370855
[TBL] [Abstract][Full Text] [Related]
17. IgG anti-melanocyte antibodies purified from patients with active vitiligo induce HLA-DR and intercellular adhesion molecule-1 expression and an increase in interleukin-8 release by melanocytes.
Li YL; Yu CL; Yu HS
J Invest Dermatol; 2000 Dec; 115(6):969-73. PubMed ID: 11121127
[TBL] [Abstract][Full Text] [Related]
18. Cytokines: the yin and yang of vitiligo pathogenesis.
Singh M; Kotnis A; Jadeja SD; Mondal A; Mansuri MS; Begum R
Expert Rev Clin Immunol; 2019 Feb; 15(2):177-188. PubMed ID: 30462555
[TBL] [Abstract][Full Text] [Related]
19. T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo.
Tembhre MK; Sharma VK; Sharma A; Chattopadhyay P; Gupta S
Clin Chim Acta; 2013 Sep; 424():27-32. PubMed ID: 23680073
[TBL] [Abstract][Full Text] [Related]
20. New insights into immune mechanisms of vitiligo.
Boniface K; Taïeb A; Seneschal J
G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
